CD4 and myocardial infarction: In vivo, though we found no significant difference in the number of cardiac DCs between PBS‐treated and rIL‐38‐treated mice with MI, rIL‐38 significantly reduced the levels of inflammatory cytokines which are related to DCs and CD4+ cells.